Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
ABSTRACTSHWETA SHAH. Survival, healthcare utilization and costs associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small cell lung cancer. (Under the direction of DR. CHRISTOPHER M. BLANCHETTE)Lung can...
ABSTRACTSHWETA SHAH. Survival, healthcare utilization and costs associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small cell lung cancer. (Under the direction of DR. CHRISTOPHER M. BLANCHETTE)Lung can...
ABSTRACTSHWETA SHAH. Survival, healthcare utilization and costs associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small cell lung cancer. (Under the direction of DR. CHRISTOPHER M. BLANCHETTE)Lung can...